You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.
You need to be a full subscriber to access this feature of the Switzer Super Report. Click here to upgrade your subscription or read recently answered questions below
James Dunn is a freelance finance journalist and media consultant. James was founding editor of Shares magazine, and formerly, the personal investment editor at The Australian.
His first book, Share Investing for Dummies, was published by John Wiley & Co. in September 2002: a second edition was published in March 2007...View more >
Companies bringing new copper production to the market over the next few years can expect to be looked upon very favourably by the market. Here are what I think are 3 outstanding prospects on the ASX.
Can there possibly be good buying in single-digit share prices? I’ve been trawling through the ASX-listed population looking for this kind of situation, and here are two single-digit share prices th..
The fact of biotech investing is that the share prices are at the mercy of news flow from drug trial results, partnerships with bigger companies, regulatory interactions and a wide range of other even..
There’s no shortage of world-class innovation coming out of our neighbour across the ditch. Here are three Kiwi stocks that I think are global standouts in their fields — and each of these, for va..
Here are three of the best (non-Kiwi) foreign listings: Block (Afterpay), Resmed and Zimplats.
Here’s a look at 4 of the solid- material recycling stocks that I see as leading the way in the “circular economy.”
